Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Roche patents vasopressin V1A receptor antagonists

Feb. 14, 2022

NOS targeting to treat ischemic stroke

Feb. 14, 2022

Regulating ANXA1 activity is an approach for treating sickle cell disease-associated stroke

Feb. 11, 2022

Targeting TRPM2 using tat-M2NX improves functional outcome following MCAO

Feb. 11, 2022

Researchers unveil therapeutic targets in ischemic stroke

Feb. 11, 2022

Virpax reports preclinical findings on Envelta for acute and chronic pain

Feb. 11, 2022

JR-14a shows potent neuroprotective effect in stroke models

Feb. 10, 2022

Eisai divulges new OX2 receptor agonists for narcolepsy

Feb. 9, 2022

Korean researchers synthesize PDE5A and HDAC6 dual inhibitors for Alzheimer's

Feb. 9, 2022

Non-muscle-targeted AAV8/DC190-ASM gene therapy for treating limb girdle muscular dystrophy 2B

Feb. 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...